Article Details

Ambys Medicines Debuts in Unusual Deal with Takeda Pharmaceutical

Retrieved on: 2018-08-07 21:30:00

Tags for this article:

Click the tags to see associated articles and topics

Ambys Medicines Debuts in Unusual Deal with Takeda Pharmaceutical. View article details on hiswai:

Excerpt

<div>First off, Ambys closed on a Series A round worth $60 million from <b>Third Rock</b> <b>Ventures</b> and Takeda. That's fairly typical. What is a bit unusual is ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up